ATC Group: G03G Gonadotropins and other ovulation stimulants

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of G03G in the ATC hierarchy

Level Code Title
1 G Genito urinary system and sex hormones
2 G03 Sex hormones and modulators of the genital system
3 G03G Gonadotropins and other ovulation stimulants

Group G03G contents

Code Title
G03GA Gonadotropins
G03GB Ovulation stimulants, synthetic

Active ingredients in G03G

Active Ingredient Description
Choriogonadotropin alpha

The principal pharmacodynamic activity in women is oocyte meiosis resumption, follicular rupture (ovulation), corpus luteum formation and production of progesterone and estradiol by the corpus luteum.

Chorionic gonadotrophin (human)

Human chorionic gonadotrophin stimulates the steroidogenesis in the gonads by virtue of a biological effect similar to that of LH (Luteinizing hormone, which is the same as interstitial cell stimulating hormone).

Clomifene

Clomifene is a non-steroidal agent which stimulates ovulation in a high percentage of appropriately selected anovulatory women. The ovulatory response to clomifene therapy is mediated through increased output of pituitary gonadotrophins, which in turn stimulates the maturation and endocrine activity of the ovarian follicle.

Corifollitropin alfa

Corifollitropin alfa is designed as a sustained follicle stimulant with the same pharmacodynamic profile as (rec)FSH, but with a markedly prolonged duration of FSH activity. Corifollitropin alfa does not display any intrinsic LH/hCG activity.

Cyclofenil
Follitropin alfa

In women, the most important effect resulting from parenteral administration of FSH is the development of mature Graafian follicles.

Follitropin beta

Follitropin beta is a recombinant FSH. Follitropin beta can be used to stimulate follicular development and steroid production in selected cases of disturbed gonadal function. Furthermore follitropin beta can be used to promote multiple follicular development in medically assisted reproduction programs.

Follitropin delta

Follitropin delta is a recombinant human FSH used for controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (ART). Because follitropin delta is produced in the human cell line PER.C6, the glycosylation profile is different from follitropin alfa and follitropin beta.

Lutropin alfa

Lutropin alfa is a recombinant human Luteinising Hormone (r-hLH). Luteinising Hormone (LH) binds on the ovarian theca (and granulosa) cells and testicular Leydig cells, to a receptor shared with human chorionic gonadotropin hormone (hCG). Lutropin alfa in association with a Follicle Stimulating Hormone (FSH) preparation is recommended for the stimulation of follicular development in adult women with severe Luteinising Hormone (LH) and FSH deficiency.

Menotropin
Urofollitropin

Urofollitropin contains a highly purified preparation of urinary FSH extracted from the urine of postmenopausal women. FSH stimulates ovarian follicular growth and development as well as gonadal steroid production in women who do not have primary ovarian failure.

Related product monographs

Title Information Source Document Type  
BRAVELLE Powder and solvent for solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CLOMID Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DUINUM Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
ELONVA Solution for injection European Medicines Agency (EU) MPI, EU: SmPC
FERTILAN Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
FOSTIMON Powder and solvent for solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
LUVERIS Powder and solvent for solution for injection European Medicines Agency (EU) MPI, EU: SmPC
OVA-MIT Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
OVALEAP Solution for injection European Medicines Agency (EU) MPI, EU: SmPC
OVIDREL Solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old
OVITRELLE Solution for injection in pre-filled syringe European Medicines Agency (EU) MPI, EU: SmPC
PREGNYL 5000IU Powder for solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PUREGON Solution for injection European Medicines Agency (EU) MPI, EU: SmPC
REKOVELLE Solution for injection European Medicines Agency (EU) MPI, EU: SmPC